2-([1,1'-Biphenyl]-4-yl)-6-phenylbenzo[d]oxazole

Catalog No. :
ACDWVF193
CAS No. :
17064-47-0
Molecular Formula :
C25H17NO
Molecular Weight :
347.42

IUPAC Name:2-([1,1'-biphenyl]-4-yl)-6-phenylbenzo[d]oxazole

2-([1,1'-Biphenyl]-4-yl)-6-phenylbenzo[d]oxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$82.00Login to see priceInquiryInquiry
5g95%$332.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-([1,1'-Biphenyl]-4-yl)-6-phenylbenzo[d]oxazole
IUPAC Name2-([1,1'-biphenyl]-4-yl)-6-phenylbenzo[d]oxazole
MDL No.MFCD00005768
Molecular FormulaC25H17NO
Molecular Weight347.42
SMILESC1(C2=CC=C(C3=CC=CC=C3)C=C2)=NC4=CC=C(C5=CC=CC=C5)C=C4O1
InChI KeyWISWLZYHZLVSMO-UHFFFAOYSA-N
Synonym2-(4-Biphenylyl)-6-phenylbenzoxazole, BioReagent, suitable for scintillation, >=98.0% (TLC) | Oprea1_507347 | 2-(4-Biphenylyl)-6-phenyl-1,3-benzoxazole | 2-[1,1'-Biphenyl]-4-yl-6-phenyl-1,3-benzoxazole # | SCHEMBL590701 | WISWLZYHZLVSMO-UHFFFAOYSA-N | Ben
CAS No.17064-47-0
PubChem CID86930

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACDWVF193 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACDWVF193 route product structure diagram
    ACDWVF19317064-47-0
Inquiry

2. ACDWVF193 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACDWVF193 route product structure diagram
    ACDWVF19317064-47-0
Inquiry

Comments (0)